|
|
||||||||
|
FIGURE 3. Timeconcentration curves for plasma and brain after peroral administration of FK960 (0.1 mg/kg) containing 18F-FK960 (366 ± 14 MBq). Data are presented as mean + SE, averaged over all subjects (n = 3), at each point.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |